{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:43:59Z","timestamp":1791420239621,"version":"4.3.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-90766-x","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T05:27:29Z","timestamp":1740029249000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Secondary Hemophagocytic Lymphohistiocytosis in severe COVID-19 - a retrospective cohort study"],"prefix":"10.1038","volume":"15","author":[{"given":"Julia","family":"Oppenauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Clodi-Seitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Kornfehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Wenisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Eibensteiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Brock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Neymayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Oppenauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold","family":"Pilz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Veigl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Tihanyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Strassl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermine","family":"Agis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Schnaubelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,20]]},"reference":[{"key":"90766_CR1","doi-asserted-by":"crossref","unstructured":"1. Ramos-Casals M, Brito-Zer\u00f3n P, L\u00f3pez-Guillermo A, Khamashta MA, Bosch X. Adult haemophagocytic syndrome. Lancet. 2014;383(9927):1503-16.","DOI":"10.1016\/S0140-6736(13)61048-X"},{"key":"90766_CR2","doi-asserted-by":"crossref","unstructured":"2. Mou SS, Nakagawa TA, Riemer EC, McLean TW, Hines MH, Shetty AK. Hemophagocytic lymphohistiocytosis complicating influenza A infection. Pediatrics. 2006;118(1):e216-9.","DOI":"10.1542\/peds.2005-1861"},{"key":"90766_CR3","doi-asserted-by":"crossref","unstructured":"3. Harms PW, Schmidt LA, Smith LB, Newton DW, Pletneva MA, Walters LL, et al. Autopsy findings in eight patients with fatal H1N1 influenza. Am J Clin Pathol. 2010;134(1):27\u201335.","DOI":"10.1309\/AJCP35KOZSAVNQZW"},{"key":"90766_CR4","doi-asserted-by":"crossref","unstructured":"4. Chen TL, Wong WW, Chiou TJ. Hemophagocytic syndrome: an unusual manifestation of acute human immunodeficiency virus infection. Int J Hematol. 2003;78(5):450-2.","DOI":"10.1007\/BF02983819"},{"key":"90766_CR5","doi-asserted-by":"crossref","unstructured":"5. Fardet L, Blum L, Kerob D, Agbalika F, Galicier L, Dupuy A, et al. Human herpesvirus 8-associated hemophagocytic lymphohistiocytosis in human immunodeficiency virus-infected patients. Clin Infect Dis. 2003;37(2):285\u2009\u2212\u200991.","DOI":"10.1086\/375224"},{"key":"90766_CR6","doi-asserted-by":"crossref","unstructured":"6. Grossman WJ, Radhi M, Schauer D, Gerday E, Grose C, Goldman FD. Development of hemophagocytic lymphohistiocytosis in triplets infected with HHV-8. Blood. 2005;106(4):1203-6.","DOI":"10.1182\/blood-2005-03-0950"},{"key":"90766_CR7","doi-asserted-by":"crossref","unstructured":"7. Mostaza-Fern\u00e1ndez JL, Guerra Laso J, Carriedo Ule D, Ruiz de Morales JM. Hemophagocytic lymphohistiocytosis associated with viral infections: Diagnostic challenges and therapeutic dilemmas. Rev Clin Esp (Barc). 2014;214(6):320-7.","DOI":"10.1016\/j.rceng.2014.03.004"},{"key":"90766_CR8","doi-asserted-by":"crossref","unstructured":"8. Tang KT, Hsu BC, Chen DY. Autoimmune and Rheumatic Manifestations Associated With COVID-19 in Adults: An Updated Systematic Review. Front Immunol. 2021;12:645013.","DOI":"10.3389\/fimmu.2021.645013"},{"key":"90766_CR9","doi-asserted-by":"crossref","unstructured":"9. Alam F, Becetti K, Alamlih L, Cackamvalli P, Veettil S, Awadh B, et al. Rate of secondary HLH and performance of H-score in patients with severe COVID-19. Qatar Med J. 2022;2022(2):11.","DOI":"10.5339\/qmj.2022.fqac.11"},{"key":"90766_CR10","doi-asserted-by":"crossref","unstructured":"10. Bichon A, Bourenne J, Allardet-Servent J, Papazian L, Hraiech S, Guervilly C, et al. High Mortality of HLH in ICU Regardless Etiology or Treatment. Front Med (Lausanne). 2021;8:735796.","DOI":"10.3389\/fmed.2021.735796"},{"key":"90766_CR11","unstructured":"11. Henter JI, Elinder G, Ost A. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin Oncol. 1991;18(1):29\u201333."},{"key":"90766_CR12","doi-asserted-by":"crossref","unstructured":"12. Henter JI, Horne A, Aric\u00f3 M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124\u2009\u2212\u200931.","DOI":"10.1002\/pbc.21039"},{"key":"90766_CR13","doi-asserted-by":"crossref","unstructured":"13. Fardet L, Galicier L, Lambotte O, Marzac C, Aumont C, Chahwan D, et al. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol. 2014;66(9):2613-20.","DOI":"10.1002\/art.38690"},{"key":"90766_CR14","doi-asserted-by":"crossref","unstructured":"14. Debaugnies F, Mahadeb B, Ferster A, Meuleman N, Rozen L, Demulder A, et al. Performances of the H-Score for Diagnosis of Hemophagocytic Lymphohistiocytosis in Adult and Pediatric Patients. Am J Clin Pathol. 2016;145(6):862\u2009\u2212\u200970.","DOI":"10.1093\/ajcp\/aqw076"},{"key":"90766_CR15","unstructured":"15. HScore for Reactive Hemophagocytic Syndrome [Available from: https:\/\/www.mdcalc.com\/calc\/10089\/hscore-reactive-hemophagocytic-syndrome."},{"key":"90766_CR16","doi-asserted-by":"crossref","unstructured":"16. Bordbar M, Sanaei Dashti A, Amanati A, Shorafa E, Mansoori Y, Dehghani SJ, et al. Assessment of the HScore as a predictor of disease outcome in patients with COVID-19. BMC Pulmonary Medicine. 2021;21(1):338.","DOI":"10.1186\/s12890-021-01706-0"},{"key":"90766_CR17","doi-asserted-by":"crossref","unstructured":"17. Meng M, Chen L, Zhang S, Dong X, Li W, Li R, et al. Risk factors for secondary hemophagocytic lymphohistiocytosis in severe coronavirus disease 2019 adult patients. BMC Infect Dis. 2021;21(1):398.","DOI":"10.1186\/s12879-021-06094-8"},{"key":"90766_CR18","doi-asserted-by":"crossref","unstructured":"18. Swoboda J, Wittschieber D, Sanft J, Kleemann S, Elschner S, Ihle H, et al. Bone marrow haemophagocytosis indicates severe infection with severe acute respiratory syndrome coronavirus 2. Histopathology. 2021;78(5):727\u2009\u2212\u200937.","DOI":"10.1111\/his.14281"},{"key":"90766_CR19","doi-asserted-by":"crossref","unstructured":"19. Ishii E, Ohga S, Imashuku S, Yasukawa M, Tsuda H, Miura I, et al. Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. Int J Hematol. 2007;86(1):58\u201365.","DOI":"10.1532\/IJH97.07012"},{"key":"90766_CR20","doi-asserted-by":"crossref","unstructured":"20. La Marle S, Richard-Colmant G, Fauvernier M, Ghesqui\u00e8res H, Hot A, S\u00e8ve P, et al. Mortality and Associated Causes in Hemophagocytic Lymphohistiocytosis: A Multiple-Cause-of-Death Analysis in France. J Clin Med. 2023;12(4).","DOI":"10.3390\/jcm12041696"},{"key":"90766_CR21","doi-asserted-by":"crossref","unstructured":"21. Leverenz DL, Tarrant TK. Is the HScore useful in COVID-19? Lancet. 2020;395(10236):e83.","DOI":"10.1016\/S0140-6736(20)31057-6"},{"key":"90766_CR22","doi-asserted-by":"crossref","unstructured":"22. Lorenz G, Moog P, Bachmann Q, La Ros\u00e9e P, Schneider H, Schlegl M, et al. Title: Cytokine release syndrome is not usually caused by secondary hemophagocytic lymphohistiocytosis in a cohort of 19 critically ill COVID-19 patients. Sci Rep. 2020;10(1):18277.","DOI":"10.1038\/s41598-020-75260-w"},{"key":"90766_CR23","doi-asserted-by":"crossref","unstructured":"23. Wood H, Jones JR, Hui K, Mare T, Pirani T, Galloway J, et al. Secondary HLH is uncommon in severe COVID-19. Br J Haematol. 2020;190(5):e283-e5.","DOI":"10.1111\/bjh.16934"},{"key":"90766_CR24","doi-asserted-by":"crossref","unstructured":"24. Yadav G, Malhotra H, Mehta P, Sachu R, Rizvi I, Bharti VR, et al. Severe COVID-19-associated hyperinflammatory syndrome versus classic hemophagocytic lymphohistiocytosis: similarities, differences, and the way forward. J Investig Med. 2023;71(3):244\u2009\u2212\u200953.","DOI":"10.1177\/10815589221140596"},{"key":"90766_CR25","doi-asserted-by":"crossref","unstructured":"25. Alfaro-Murillo A, Lazo-Pa\u00e9z G. [Secondary hemophagocytic lymphohistiocytosis and cytokine release syndrome in COVID-19, the same or different entities?]. Rev Chilena Infectol. 2021;38(2):271-8.","DOI":"10.4067\/S0716-10182021000200271"},{"key":"90766_CR26","doi-asserted-by":"crossref","unstructured":"26. Clark KEN, Nevin WD, Mahungu T, Lachmann H, Singh A. Assessment of the Hemophagocytic Lymphohistiocytosis HScore in Patients With Coronavirus Disease 2019. Clin Infect Dis. 2021;73(9):e3110-e2.","DOI":"10.1093\/cid\/ciaa1463"},{"key":"90766_CR27","doi-asserted-by":"crossref","unstructured":"27. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. Jama. 2020;323(11):1061-9.","DOI":"10.1001\/jama.2020.1585"},{"key":"90766_CR28","doi-asserted-by":"crossref","unstructured":"28. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507\u2009\u2212\u200913.","DOI":"10.1016\/S0140-6736(20)30211-7"},{"key":"90766_CR29","doi-asserted-by":"crossref","unstructured":"29. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. Jama. 2020;323(20):2052-9.","DOI":"10.1001\/jama.2020.6775"},{"key":"90766_CR30","doi-asserted-by":"crossref","unstructured":"30. Kornblith LZ, Sadhanandhan B, Arun S, Long R, Johnson AJ, Noll J, et al. \u03b3\u2019 fibrinogen levels as a biomarker of COVID-19 respiratory disease severity. Blood Cells Mol Dis. 2023;101:102746.","DOI":"10.1016\/j.bcmd.2023.102746"},{"key":"90766_CR31","doi-asserted-by":"crossref","unstructured":"31. Wei X, Zeng W, Su J, Wan H, Yu X, Cao X, et al. Hypolipidemia is associated with the severity of COVID-19. J Clin Lipidol. 2020;14(3):297\u2013304.","DOI":"10.1016\/j.jacl.2020.04.008"},{"key":"90766_CR32","doi-asserted-by":"crossref","unstructured":"32. Cao WJ, Wang TT, Gao YF, Wang YQ, Bao T, Zou GZ. Serum Lipid Metabolic Derangement is Associated with Disease Progression During Chronic HBV Infection. Clin Lab. 2019;65(12).","DOI":"10.7754\/Clin.Lab.2019.190525"},{"key":"90766_CR33","doi-asserted-by":"crossref","unstructured":"33. Madsen CM, Varbo A, Tybj\u00e6rg-Hansen A, Frikke-Schmidt R, Nordestgaard BG. U-shaped relationship of HDL and risk of infectious disease: two prospective population-based cohort studies. Eur Heart J. 2018;39(14):1181-90.","DOI":"10.1093\/eurheartj\/ehx665"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90766-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90766-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90766-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T05:27:47Z","timestamp":1740029267000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90766-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,20]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["90766"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-90766-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,20]]},"assertion":[{"value":"28 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval (N\u00b020-079-VK) was provided by the Ethics Committee of the City of Vienna. Due to the retrospective nature of the study, the Ethics Committee of the City of Vienna waived the need of obtaining informed consent. The study complies with the Declaration of Helsinki and STROBE guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent (and therefore also consent for publication) was waived by the Ethics Committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6137"}}